Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2022 Filed Feb 14, 2022 19:17 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 7,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000024 · wf-form4_164488420854201.xml · derivative · entry 3 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 7,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 14, 2022 19:17 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
Exercise / conversionCommon Shares | 7,010 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000024 · wf-form4_164488420854201.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2022 Filed Feb 14, 2022 19:15 UTC |
Kunkel Jay K.Director
|
Exercise / conversionDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000021 · wf-form4_164488411062058.xml · derivative · entry 3 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 14, 2022 19:15 UTC |
Kunkel Jay K.Director
|
Exercise / conversionCommon Stock | 5,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000021 · wf-form4_164488411062058.xml · nonDerivative · entry 1 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 00:16 UTC |
Chertoff Jocelyn DDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000023 · wf-form4_164488418534488.xml · derivative · entry 3 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 00:16 UTC |
Chertoff Jocelyn DDirector
|
Exercise / conversionCommon Stock | 5,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000023 · wf-form4_164488418534488.xml · nonDerivative · entry 1 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:47 UTC |
Rosebrough Walter M JrDirector
|
Exercise / conversionDeferred Stock Units · Derivative | 5,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000027 · wf-form4_164496162204969.xml · derivative · entry 3 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,098 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. F4 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:47 UTC |
Rosebrough Walter M JrDirector
|
Exercise / conversionCommon Stock | 5,098 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-22-000027 · wf-form4_164496162204969.xml · nonDerivative · entry 1 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: 14,000 of these Common Shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:16 UTC |
TSINGOS CHRISTINE ADirector
|
GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · derivative · entry 2 TSINGOS CHRISTINE A · CIK 0001278861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:17 UTC |
GUERTIN TIMOTHY EDirector
|
GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000025 · wf-form4_164488423653861.xml · derivative · entry 1 GUERTIN TIMOTHY E · CIK 0001217440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:17 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
GrantDeferred Stock Units · Derivative | 9,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000024 · wf-form4_164488420854201.xml · derivative · entry 2 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,038 Underlying: Common Stock · 9,038 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 19:15 UTC |
Kunkel Jay K.Director
|
GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000021 · wf-form4_164488411062058.xml · derivative · entry 2 Kunkel Jay K. · CIK 0001592005 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 00:16 UTC |
Chertoff Jocelyn DDirector
|
GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000023 · wf-form4_164488418534488.xml · derivative · entry 2 Chertoff Jocelyn D · CIK 0001701927 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F2 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 21:47 UTC |
Rosebrough Walter M JrDirector
|
GrantDeferred Stock Units · Derivative | 6,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-22-000027 · wf-form4_164496162204969.xml · derivative · entry 2 Rosebrough Walter M Jr · CIK 0001413087 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,573 Underlying: Common Stock · 6,573 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. F3 · derivative.expiration_date: These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the date of the first annual meeting following the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 Annual Meeting (ii) a change in control or (iii) the reporting person's termination of service for any reason. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 17:19 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 31,428 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001681622-21-000119 · wf-form4_164090278202037.xml · derivative · entry 6 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,428 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The non-qualified stock options were subject to a three-year vesting period. One third vested on February 13, 2016, and the remaining two-thirds vested on a pro-rata basis monthly thereafter. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 17:19 UTC |
SANYAL SUNNYDirector · President and CEO
|
SaleCommon Stock | 31,428 | $32.28 | $1,014,495.84 |
DisclosureSEC source: 0001681622-21-000119 · wf-form4_164090278202037.xml · nonDerivative · entry 4 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,626 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 16, 2021. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.02 to $32.43. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 29, 2021 Filed Dec 30, 2021 17:19 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 31,428 | $30.74 | $966,096.72 |
DisclosureSEC source: 0001681622-21-000119 · wf-form4_164090278202037.xml · nonDerivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 17:19 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 30,473 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001681622-21-000119 · wf-form4_164090278202037.xml · derivative · entry 5 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,428 Underlying: Common Stock · 30,473 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The non-qualified stock options were subject to a three-year vesting period. One third vested on February 13, 2016, and the remaining two-thirds vested on a pro-rata basis monthly thereafter. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 17:19 UTC |
SANYAL SUNNYDirector · President and CEO
|
SaleCommon Stock | 30,473 | $32.01 | $975,440.73 |
DisclosureSEC source: 0001681622-21-000119 · wf-form4_164090278202037.xml · nonDerivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,626 F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 16, 2021. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.13. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 17:19 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 30,473 | $30.74 | $936,740.02 |
DisclosureSEC source: 0001681622-21-000119 · wf-form4_164090278202037.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 17:02 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,602 | $0.00 Strike: $30.74 | $0.00 |
DisclosureSEC source: 0001681622-21-000117 · wf-form4_164064255611624.xml · derivative · entry 3 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,901 Underlying: Common Stock · 8,602 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The non-qualified stock options were subject to a three-year vesting period. One-third vested on February 13, 2016, and the remaining two-thirds vested on a pro-rata basis monthly thereafter. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 17:02 UTC |
SANYAL SUNNYDirector · President and CEO
|
SaleCommon Stock | 8,602 | $32.00 | $275,264.00 |
DisclosureSEC source: 0001681622-21-000117 · wf-form4_164064255611624.xml · nonDerivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,626 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 16, 2021. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.03. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 17:02 UTC |
SANYAL SUNNYDirector · President and CEO
|
Exercise / conversionCommon Stock | 8,602 | $30.74 | $264,425.48 |
DisclosureSEC source: 0001681622-21-000117 · wf-form4_164064255611624.xml · nonDerivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 2,945 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:45 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
GrantRestricted Stock Units · Derivative | 9,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000111 · wf-form4_163952551563801.xml · derivative · entry 2 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,328 Underlying: Common Stock · 9,328 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:45 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,748 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000111 · wf-form4_163952551563801.xml · derivative · entry 1 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,748 Underlying: Common Stock · 21,748 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:46 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
GrantRestricted Stock Units · Derivative | 10,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000115 · wf-form4_163952558823348.xml · derivative · entry 2 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,216 Underlying: Common Stock · 10,216 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:46 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 23,819 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000115 · wf-form4_163952558823348.xml · derivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,819 Underlying: Common Stock · 23,819 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:46 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantRestricted Stock Units · Derivative | 9,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000114 · wf-form4_163952557325694.xml · derivative · entry 2 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,328 Underlying: Common Stock · 9,328 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:46 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,748 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000114 · wf-form4_163952557325694.xml · derivative · entry 1 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,748 Underlying: Common Stock · 21,748 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:46 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 53,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000113 · wf-form4_163952555506417.xml · derivative · entry 2 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,304 Underlying: Common Stock · 53,304 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:46 UTC |
SANYAL SUNNYDirector · President and CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 124,275 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000113 · wf-form4_163952555506417.xml · derivative · entry 1 SANYAL SUNNY · CIK 0001599398 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,275 Underlying: Common Stock · 124,275 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:45 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 14,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000112 · wf-form4_163952553885850.xml · derivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,125 Underlying: Common Stock · 14,125 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 18:45 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 32,932 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000112 · wf-form4_163952553885850.xml · derivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,932 Underlying: Common Stock · 32,932 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 23:45 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
GrantRestricted Stock Units · Derivative | 9,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000110 · wf-form4_163952548818987.xml · derivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,328 Underlying: Common Stock · 9,328 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on December 10, 2021 vest 50% on December 10, 2023 and 50% on December 10, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 23:45 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 21,748 | $0.00 Strike: $30.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000110 · wf-form4_163952548818987.xml · derivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,748 Underlying: Common Stock · 21,748 shares Expires 2031-12-10 F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 23:52 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionRestricted Stock Units · Derivative | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000090 · wf-form4_162933069179001.xml · derivative · entry 3 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,638 Underlying: Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 23:52 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Tax withholdingCommon Stock | 480 | $27.58 | $13,238.40 |
DisclosureSEC source: 0001681622-21-000090 · wf-form4_162933069179001.xml · nonDerivative · entry 2 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,594 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 23:52 UTC |
Hartmann AndrewSVP Sales & Marketing, Medical
|
Exercise / conversionCommon Stock | 1,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000090 · wf-form4_162933069179001.xml · nonDerivative · entry 1 Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| May 21, 2021 Filed May 25, 2021 18:40 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 17,605 | $0.00 Strike: $27.95 | $0.00 |
DisclosureSEC source: 0001681622-21-000071 · wf-form4_162198242966672.xml · derivative · entry 2 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,605 Underlying: Common Stock · 17,605 shares Expires 2031-05-21 F3 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on May 15, 2022 and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| May 21, 2021 Filed May 25, 2021 18:40 UTC |
Maheshwari ShubhamChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 7,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000071 · wf-form4_162198242966672.xml · derivative · entry 1 Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,378 Underlying: Common Stock · 7,378 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · derivative.exercise_date: These Restricted Stock Units granted on May 21, 2021 vest 50% on May 15, 2023 and 50% on May 15, 2025. Vested shares will be delivered to the reporting person upon vest date. F2 · derivative.expiration_date: These Restricted Stock Units granted on May 21, 2021 vest 50% on May 15, 2023 and 50% on May 15, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:08 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionRestricted Stock Units · Derivative | 863 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000069 · wf-form4_162138286543456.xml · derivative · entry 3 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 863 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: The Restricted Stock Units granted on May 25, 2017 vest 25% each year for four years beginning on May 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: The Restricted Stock Units granted on May 25, 2017 vest 25% each year for four years beginning on May 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:08 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Tax withholdingCommon Stock | 296 | $23.93 | $7,083.28 |
DisclosureSEC source: 0001681622-21-000069 · wf-form4_162138286543456.xml · nonDerivative · entry 2 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,111 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:08 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
Exercise / conversionCommon Stock | 863 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001681622-21-000069 · wf-form4_162138286543456.xml · nonDerivative · entry 1 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:24 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
SaleCommon Stock | 2,970 | $24.00 | $71,280.00 |
DisclosureSEC source: 0001681622-21-000064 · wf-form4_162017065253033.xml · nonDerivative · entry 1 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,363 F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on March 11, 2021. All shares were sold at $24.00 F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflects 150 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:15 UTC |
NAUMANN-ETIENNE RUEDIGERDirector
|
SaleCommon Stock | 4,264 | $23.89 | $101,866.96 |
DisclosureSEC source: 0001681622-21-000052 · wf-form4_161489972657427.xml · nonDerivative · entry 1 NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,572 F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.85 to $23.90. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 21:56 UTC |
Yankton Kevin BruceChief Accounting Officer
|
SaleCommon Stock | 956 | $22.66 | $21,662.96 |
DisclosureSEC source: 0001681622-21-000050 · wf-form4_161403096763561.xml · nonDerivative · entry 1 Yankton Kevin Bruce · CIK 0001697197 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on Jan 19, 2021. All shares were sold at $22.66. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 20:27 UTC |
Giambattista Brian WSVP and GM, X-ray Detectors
|
GrantRestricted Stock Units · Derivative | 11,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000037 · wf-form4_161361164991185.xml · derivative · entry 4 Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,523 Underlying: Common Stock · 11,523 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 20:28 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 28,195 | $0.00 Strike: $25.06 | $0.00 |
DisclosureSEC source: 0001681622-21-000038 · wf-form4_161361167336746.xml · derivative · entry 7 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,195 Underlying: Common Stock · 28,195 shares Expires 2031-02-16 F5 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 20:28 UTC |
Honeysett Kimberley E.SVP and General Counsel
|
GrantRestricted Stock Units · Derivative | 11,523 | $0.00 | $0.00 |
DisclosureSEC source: 0001681622-21-000038 · wf-form4_161361167336746.xml · derivative · entry 6 Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,523 Underlying: Common Stock · 11,523 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2021 vest 50% on February 15, 2023 and 50% on February 15, 2025. Vested shares will be delivered to the reporting person upon vest date. Read SEC document |
| February 16, 2021 Filed Feb 17, 2021 21:14 UTC |
Jonaitis Mark S.SVP and GM, X-Ray Sources
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 28,195 | $0.00 Strike: $25.06 | $0.00 |
DisclosureSEC source: 0001681622-21-000041 · wf-form4_161361442828996.xml · derivative · entry 6 Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,195 Underlying: Common Stock · 28,195 shares Expires 2031-02-16 F5 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest one year from grant date, and the remaining options vest monthly thereafter on a pro rata basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.